Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice

Journal of Immunology

Volumn 175, Issue 10, 2005, Pages 6820-6828

  Dighe, Abhijit ^a   Rodriguez, Marisela ^a   Sabastian, Pearl ^a   Xie, Xuefang ^a   McVoy, Michael ^b   Brown, Michael G ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LY49H RECEPTOR; LYMPHOCYTE MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LY49H; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG; H2 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BACKCROSSING; CONGENIC STRAIN; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DELETION MUTANT; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN CYTOMEGALOVIRUS; HYBRIDOMA CELL CULTURE; IMMUNE DEFICIENCY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROGENY; REGRESSION ANALYSIS; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BETAHERPESVIRINAE; C57BL MOUSE; CYTOMEGALIC INCLUSION BODY DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUSE STRAIN; PATHOGENICITY; VIROLOGY;

ANIMALS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; H-2 ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MUROMEGALOVIRUS; POLYMORPHISM, GENETIC;

EID: 27744516887     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.10.6820     Document Type: Article

References (38)

1. Beutler, B., K. Crozat, J. A. Koziol, and P. Georgel. 2005. Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model. Curr. Opin. Immunol. 17: 36-43.
2. Scalzo, A. A., N. A. Fitzgerald, A. Simmons, A. B. La Vista, and G. R. Shellam. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171: 1469-1483.
3. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
4. Smith, H. R. C., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
5. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. C. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
6. Lee, S. H., S. Girard, D. Macina, M. Busa, A. Zafer, A. Belouchi, P. Gros, and S. M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28: 42-45.
7. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194: 29-44.
8. Dokun, A. O., S. Kim, H. R. Smith, H. S. Kang, D. T. Chu, and W. M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2: 951-956.
9. Chalmer, J. E., J. S. Mackenzie, and N. F. Stanley. 1977. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. Gen. Virol. 37: 107-114.
10. Grundy, J. E., J. S. Mackenzie, and N. F. Stanley. 1981. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 32: 277-286.
11. Wykes, M. N., G. R. Shellam, J. McCluskey, W. M. Kast, P. B. Dallas, and P. Price. 1993. Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection. J. Virol. 67: 4182-4189.
12. Tay, C. H., R. M. Welsh, and R. R. Brutkiewicz. 1995. NK cell response to viral infections in β2-microglobulin-deficient mice. J. Immunol. 154: 780-789.
13. Polic, B., S. Jonjic, I. Pavic, I. Crnkovic, I. Zorica, H. Hengel, P. Lucin, and U. H. Koszinowski. 1996. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol. 77: 217-225.
14. + T cells and NK cells in vivo. Nat. Immunol. 3: 529-535.
15. Lodoen, M., G. Abenes, S. Umamoto, J. P. Houchins, F. Liu, and L. L. Lanier. 2004. The cytomegalovirus m155 gene product subverts natural killer cell anti-viral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200: 1075-1081.
16. Krmpotic, A., M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegeskorte, E. Pernjak-Pugel, et al. 2005. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201: 211-220.
17. Abenes, G., K. Chan, M. Lee, E. Haghjoo, J. Zhu, T. Zhou, X. Zhan, and F. Liu. 2004. Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice. J. Virol. 78: 6891-6899.
18. Raulet, D. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3: 781-790.
19. Rodriguez, M., P. Sabastian, P. Clark, and M. G. Brown. 2004. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus infected New Zealand White mice. J. Immunol. 173: 6312-6318.
20. Scalzo, A. A., P. A. Lyons, N. A. Fitzgerald, C. A. Forbes, W. M. Yokoyama, and G. R. Shellam. 1995. Genetic mapping of Cmv1 in the region of mouse chromosome 6 encoding the NK gene complex-associated loci Ly49 and musNKR-P1. Genomics 27: 435-441.
21. Scalzo, A. A., M. Manzur, C. A. Forbes, M. G. Brown, and G. R. Shellam. 2005. Natural killer gene complex haplotype variability and host resistance alleles to murine cytomegalovirus in wild mouse populations. Immunol. Cell Biol. 83: 144-149.
22. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
23. Brown, M. G., A. A. Scalzo, L. R. Stone, P. Clark, Y. Du, B. Palanca, and W. M. Yokoyama. 2001. Nkc allelic variability among inbred mouse strains: Evidence for Nkc haplotypes. Immunogenetics 53: 584-591.
24. + IL-2-activated natural killer cells. Nature 358: 66-70.
25. Abbate, J., J. C. Lacayo, M. Prichard, G. Pari, and M. A. McVoy. 2001. Bifunctional protein conferring enhanced green fluorescence and puromycin resistance. BioTechniques 31: 336-340.
26. Wheat, R. L., P. Y. Clark, and M. G. Brown. 2003. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J. Virol. Methods 112: 107-113.
27. Manly, K. F., R. H. Cudmore, and J. M. Meer. 2001. Map Manager QTX, cross-platform software for genetic mapping. Mamm. Genome 12: 930-932.
28. Manly, K. F., and J. M. Olson. 1999. Overview of QTL mapping software and introduction to Map Manager QT. Mamm. Genome 10: 327-334.
29. Beck, J. A., S. Lloyd, M. Hafezparast, M. Lennon-Pierce, J. T. Eppig, M. F. Festing, and E. M. Fisher. 2000. Genealogies of mouse inbred strains. Nat. Genet. 24: 23-25.
30. Orange, J. S. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4: 1545-1558.
31. Bancroft, G. J., G. R. Shellam, and J. E. Chalmer. 1981. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126: 988-994.
32. Desrosiers, M.-P., A. Kielczewska, J.-C. Loredo-Osti, S. G. Adam, A. P. Makrigiannis, S. Lemieux, T. Pham, M. Lodoen, K. Morgan, L. L. Lanier, and S. M. Vidal. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37: 593-599.
33. Wagner, M., A. Gutermann, J. Podlech, M. J. Reddehase, and U. H. Koszinowski. 2002. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196: 805-816.
34. Liao, N. S., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253: 199-202.
35. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
36. Johansson, S., M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr, M. Salmon-Divon, F. Lemonnier, K. Karre, and P. Hoglund. 2005. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201: 1145-1155.
37. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski. J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
38. Dietrich, W. F., J. C. Miller, R. G. Steen, M. Merchant, D. Damron, R. Nahf, A. Gross, D. C. Joyce, M. Wessel, R. D. Dredge, et al. 1994. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat. Genet. 7: 220-245.